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Objectives: To assess outcomes and develop duplex scan criteria that will reliably determine the luminal status of covered
and uncovered renal stents following fenestrated and branched endovascular repair.
Methods:A prospective database of patients treated with fenestrated and branched endografts between 2001 and 2006was
reviewed. All patients with evidence of renal artery pathology including duplex scan assessed peak systolic velocity (PSV)
<50 or>200 cm/s, renal aortic ratio (RAR)>3.5, elevation of the serum creatinine>30%, computed tomography (CT)
evidence of renal stenosis underwent further analyses including medical chart review, and a review of CT and duplex scan
imaging data. Correlations of ultrasound scan, CT, angiographic, and clinical outcomes were conducted and receiver
operator curve (ROC) analysis was performed. Freedom from stenosis or occlusion was determined by Kaplan-Meier
analysis with differences assessed by log rank tests.
Results: A total of 518 renal arteries were treated with uncovered or covered renal stents (287 patients). Mean follow-up
was 25 months. The estimated freedom from stenosis at 12, 24, and 36 months were 95% (95% confidence interval [CI]
93-98), 92% (89-96), and 89% (85-93) for uncovered stents, and 98% (96-100), 97% (95-100), and 95% (91-100) for
covered stents (log rank P .04). Secondary interventions were performed in 20% of the patients who developed stenoses.
Only one of the detected stenoses that was not treated with a secondary intervention progressed to occlusion. Duplex scan
criteria derived from ROC analysis correlating with curved planar reconstruction (CPR) from axial imaging data
calculated a 60-99% in-stent stenosis to be associated with a PSV >280 cm/s or RAR >4.5. Occlusions were best
identified by a mid renal artery PSV <57 cm/s in conjunction with an RAR <1.2.
Conclusion:Revised ultrasound scan criteria have been developed to improve the sensitivity and specificity of non-invasive
interrogation of renal stents following endovascular aneurysm repair (EVAR). Covered renal stents are associated with a
lower incidence of in-stent stenosis and are thus recommended over uncovered stents for use in fenestrated or branched
endografts. ( J Vasc Surg 2009;49:827-37.)Renal stenting has been advocated as a method to treat
renal arterial disease in the setting of deteriorating renal
function or poorly controlled renovascular hyperten-
sion.1-4 Balloon-expandable stents are primarily utilized to
treat ostial lesions, while angioplasty alone has been advo-
cated for more distal lesions.5 Recently, pure endovascular
treatment of juxtarenal and thoracoabdominal aneurysms
has been described.6-10 Specific renal outcomes have been
previously reported with an initial series of patients,11 yet
scientifically-derived criteria for assessing renal artery pa-
thology following simple renal stenting or fenestrated/
branched grafting is absent. The choice of stent type, device
sizing, and the use of covered stents is similarly founded by
bias rather than data. Some groups have postulated higher
rates of in-stent thrombosis with the bulkiness associated
with covered stents12 whilst others consider the potential
for neointimal hyperplasia between stent struts to support
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doi:10.1016/j.jvs.2008.11.024the use of drug-coated stents. No studies exist where mul-
tiple imaging modalities are used to interrogate the study
population through extended follow-up periods.
Duplex ultrasonography scan is considered the primary
test utilized to assess for de novo renal stenoses, and criteria
in the absence of intervention have been suggested.13 The
techniques used to preserve renal flow in juxtarenal aneu-
rysms, and bridge aortic graft material to the renal arteries
in thoracoabdominal aneurysms, most commonly involves
the use of renal stents. In amanner akin to renal stenting for
renal ostial stenoses, stents are placed into the main renal
trunk and intended to extend 1-3 mm into the aorta.
Following renal stent implantation or endografting in con-
junction with renal stenting, ultrasonographic criteria used
to indicate stenoses within or remote from the stented
artery are poorly defined. Some groups have continued to
use criteria applied to unstented renal arteries14,15 (peak
systolic velocity [PSV] 200 cm/s or renal aortic ratio
[RAR] 3.5), while others have suggested modified crite-
ria.16,17 None have suggested revised criteria to be used in
the setting of an aortic endovascular graft. The protrusion
of a renal stent into the aorta results in turbulence, typically
with higher PSVs; while the loss of vascular compliance
imposed by an endovascular graft alters aortic velocities.
The combination of these two factors has the potential to
markedly distort the renal to aortic ratio, resulting in con-
827
JOURNAL OF VASCULAR SURGERY
April 2009828 Mohabbat et alfusion regarding the status of a renal artery after treatment.
Therefore, in the absence of follow-up imaging studies,
supplementing duplex ultrasound scan data are of little use
without a method of validating the duplex scan results. The
intention of this study was to assess the methods by which
the covered and uncovered renal stents used in conjunction
with an aortic graft are assessed, and to evaluate the out-
comes in the context of clinical relevance.
MATERIALS AND METHODS
Between August 2001 and December 2006, 295 pa-
tients underwent endovascular repair of juxtarenal (166) or
thoracoabdominal (129) aortic aneurysms with fenestrated
or branched devices. Procedures were performed under a
sponsored physician investigational device exemption
study. All patients signed an informed consent form that
had been approved by our institutional review board. Pa-
tients were considered high risk for open surgery, based
upon physiologic and anatomic characteristics.8 The tech-
niques used to implant these prostheses have also been
previously described.8 The presence of a renal stenosis prior
to aneurysm treatment was not a contraindication for treat-
ment, and all patients underwent renal angiography at the
time of the aneurysm repair. Patients were included in this
analysis only if follow-up duplex scan and CT data were
available (Table I), they were not on dialysis prior to the
aneurysm repair, and the device utilized required the stent-
ing of one or more renal arteries. A total of 8 patients were
excluded from the analysis because no renal arteries were
involved in their repair, or directional branches for the renal
arteries were utilized. The procedural records and imaging
studies were reviewed for the remaining 287 patients. Anal-
ysis was performed per renal artery treated for a total of 518
renal arteries.
Techniques. Our experience began with treatment of
juxtarenal aortic aneurysms with fenestrated endografts
using uncovered balloon-expandable renal stents in 2001.8
Covered stents were later employed in the setting of thora-
coabdominal aneurysms and selectively in juxtarenal aneu-
rysms.18 Both JOMED (Abbott Vascular, Redwood City,
Calif) and iCast (AtriumMedical Corp, Hudson, NH) have
been used. Since 2006, covered stents have been used for
both thoracoabdominal as well as juxtarenal aneurysms.
The stresses and angulations imposed on the renal stents
may differ between some thoracoabdominal aneurysms and
juxtarenal aneurysms.
In brief, access from the contralateral femoral artery is
Table I. Patient accountability through 24 months
Number of patients (%)
Eligible for visit Followed CT US
1 years 235 205 (87) 193 (82) 169 (72)
2 years 126 107 (85) 107 (85) 101 (80)
CT, Computed tomography; US, ultrasound scan.utilized to cannulate fenestrations from within the partiallydeployed prosthesis. Guiding sheaths are placed within the
fenestrations and the proximal fixation system is completely
released.
The renal arteries are imaged through the guiding
sheaths and a balloon catheter is selected to match the renal
artery diameter. The stent is then delivered on the balloon
and positioned such that the majority of the stent is within
the renal artery and 2-4 mm project into the aorta. The
aortic portion of the stent is then flared with a 10-12 mm
angioplasty balloon, allowing it to function as a rivet,
apposing the aortic graft material against the renal orifice.
The remainder of the procedure is carried out in a manner
similar to a conventional bifurcated Zenith (Cook Inc,
Bloomington, Ind) abdominal aortic aneurysm (AAA) en-
dograft.
Technical success was defined as the placement of a
patent endoprosthesis with all vessels initially intended to
be incorporated into the desired fenestration remaining
patent, in addition to the absence of a type I or III endoleak
at the completion angiogram.
Evidence of renal arterial issues. A conglomerate
endpoint was established intended to capture all renal
stenoses or occlusion during follow-up. To accomplish this,
given the lack of appropriate guidelines to identify patients
with renal artery stenosis or occlusion following aortic
repair, the criteria were intentionally broad in an effort to
include all patients with potential renal artery compromise.
All renal ultrasound scans were classified in one of six ways:
normal, 60-99% renal artery stenosis (PSV 200 cm/s or
RAR 3.5), 80% renal artery stenosis (end-diastolic ve-
locity [EDV] 140 cm/s), potential renal artery stenosis
(any value of a PSV 200 cm/sec or 50 sm/sec), renal
artery occlusion or other (no flow, not visualized, not
determined). Additionally, patients with any renal stent
stenosis, occlusion, or fracture noted on any follow-up CT
scan were selected for further review. Hence all patients
with an identifiable anatomic defect were included in this
review.
Clinical events were considered to have occurred under
the following circumstances: sustained decrease in the cal-
culated Glomerular Filtration Rate (GFR) (using the Mod-
ification of Diet in Renal Disease [MDRD] formula,19 Fig 1)
of 30% or more, a significant decrease in renal size (10
mm reduction in renal length), any renal-directed second-
ary intervention, temporary or permanent dialysis, new-
onset or worsening of hypertension. All patients with any of
the above clinical events were also selected for further
review.
CT scans were reconstructed by using thin-slice algo-
rithms (with z-plane resolution typically between 0.75 mm
and 1mm) and were assessed bymultiplanar reconstruction
(MPR), three-dimensional (3D), and centerline of flow
(CLF) techniques using a 3D workstation (Aquarius, Ter-
arecon, San Mateo, Calif). Following the creation of a
centerline through each renal artery, a curved planar recon-
struction (CPR) image was generated for each renal artery
that allowed optimal visualization of each treated vessel.
CPR is a technique for reformatting axial CT data using
, Glom
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tubular structure within a single image and has been previ-
ously validated.20 Renal size was measured on 3D recon-
structions by taking the greatest cranial to caudal measure-
ment from the upper pole to the lower pole. Renal stenoses
were considered relevant on CT image processing if any of
the following were observed: a luminal stenosis of 50%
was visible on the CPR; renal stent kinked or crushed on
stent template reconstructions; lack of renal parenchymal
enhancement on 3D reconstructions associated with a re-
duction in renal size suggested stent occlusion; lack of
luminal opacification on axial, MPR, and CPRs of post-
contrast scans confirmed renal stent occlusion. Following
identification of potential renal arterial compromise from
any of the aforementioned criteria (duplex scan, clinical, or
CT), a detailed analysis of the renal data available was
conducted for each patient. All patient factors were charted
in a longitudinal manner.
Curve planar reconstructions (CPR) of the renal artery
correlated well with both PSV and RAR. Additional corre-
lation was noted as during the longitudinal follow-up of
patients with renal lesions with or without secondary inter-
ventions. Binary values were ascribed to specific renal arter-
ies as stenotic (50% luminal narrowing) or non-stenotic
(luminal narrowing 50%) based on CPR assessment.
Then, based upon the constructed ROC curves, we deter-
mined the optimum point on each ROC curve to assess for
a threshold value for PSV, EDV, and RAR that had the
highest combination of sensitivity and specificity.
Follow-up protocols. Throughout the study period,
patients have been maintained on single antiplatelet ther-
apy with aspirin (acetylsalicylic acid [ASA]), unless other
indications for more aggressive antiplatelet or anticoagu-
lant were present. Follow-up studies were conducted at
discharge, 1 month, 6 months, 12 months, and yearly
thereafter and included routine laboratory studies, renal
and mesenteric duplex scans, and CT scans. Secondary
interventions were performed for renal stent stenoses that
were associated with a deterioration of hypertension con-
trol, deterioration in renal function, progressive on serial
follow-up, or considered high grade on duplex ultrasound
scans and computed tomographic angiography (CTA) re-
constructions.
Statistical analysis. Data were stored in a database
usingOracle Clinical software S-Plus 7.0 (Insightful,Wash)
and NCSS 2007 (NCSS, Kaysville, Utah) were used for all
statistical analyses. Categorical variables were summarized
as number and percentage, continuous variables as mean
and standard deviation (SD). Comparisons between cate-
Fig 1. Modification of Diet in Renal Disease (MDRD) fo
MW, et al. National Kidney Foundation practice guidel
stratification. Ann Intern Med 2003;139(2):137-47. GFRgorical and continuous outcomes were performed with the2 test and t test, respectively. Freedom from stenosis,
freedom from occlusion and mortality were evaluated with
life table analysis using the Kaplan-Meier method. Differ-
ences in outcomes between renal arteries with covered and
uncovered stents were evaluated with the log rank test. The
outcomes of renal arteries with covered stents vs uncovered
stents were compared using Cox proportional hazards
models, and strength with the hazard ratio (HR) and 95%
confidence intervals (CI).
We further evaluated the discriminative ability of PSV,
EDV, and RAR for the diagnosis of stenosis and occlusion
by CT scan by using ROC curve analysis. The c-statistic,
equivalent to the area under the ROC curve and a measure
of discrimination, ranges from 0.5 (no discrimination) to 1
(perfect discrimination). An ROC curve was built for PSV,
EDV, and RAR, and the best combination of sensitivity and
specificity is given by the point in the curve that is closer to
the top left angle. These combinations are related to values
of PSV, EDV, and RAR, which were regarded as the best
diagnostic thresholds. The respective positive predictive
values (PPV) and negative predictive values (NPV) for each
threshold were calculated.
RESULTS
A total of 518 renal arteries were treated with uncov-
ered stents (287) or covered stents (231) in 287 patients.
The mean follow-up was 26 months (33 and 15 months,
respectively, for uncovered and covered stents) with a range
of 9 months to 6 years. The baseline characteristics of the
two groups are presented in Table II. All patients who had
a. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes
or chronic kidney disease: evaluation, classification, and
erular Filtration Rate; Pcr, polymerase chain reaction.
Table II. Baseline characteristics comparing patients
treated with covered renal artery stents to those with
uncovered renal artery stents
Uncovered stents Covered stents
Number of patients 158 129
Number of renal stents 287 231
Age at inclusion (years) 75.7*  7.1 75.8*  7.9
Gender/male, n (%) 132 (84%) 104 (81%)
Systolic BP (mm Hg) 135*  22 130*  21
Diastolic BP (mm Hg) 74*  10 72*  10
Heart rate (bpm) 71*  11 72*  13
Diabetes, n (%) 27 (17%) 19 (15%)
Current smoker, n (%) 26 (18%) 14 (18%)
Renal status (Cr) 1.2*  0.4 1.4*  0.8
Hemoglobin (g/dL) 13.5*  1.8 13.6*  1.7
BP, Blood pressure; n, number of patients; bpm, beats per minute; Cr,
creatinine.rmul
ines funcovered stents placed had a juxtarenal aneurysm. Of the
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renal, and 51% had a thoracoabdominal aneurysm. Tech-
nical success was achieved in 98.1% of cases. Successful
access into all but three of the 518 targeted renal arteries
was achieved at the time of the initial procedure. The
30-day mortality rate was 1.9% for juxtarenal aneurysms
and 6.9% for thoracoabdominal aneurysms (types I-IV) and
4.2% for the entire group.
Renal stent occlusion. A total of 13 of 287 (4.5%)
uncovered renal stents occluded on follow-up imaging.
The mean time to occlusion was 3.7 months (SD 3.3,
range, 0-9). There were 6 patients who underwent angiog-
raphy and 2 of these occlusions were recanalized and re-
main patent to date. The mean stent diameter for this
group was 6.5 mm (SD .85, range, 5-7) which did not
differ from patients without occlusions. Of the 13 patients
with renal stent occlusions, 12 had a30% deterioration in
GFR at the time of occlusion. This drop in GFR was
sustained in only seven of these cases and the other patients
recovered GFR.
A total of five of 231 (2.2%) covered renal stents
occluded on follow-up imaging. The mean time to occlu-
sion was 3.2 months (SD 2.5, range, 2-7). Two patients
with occlusions underwent angiography but neither was
successfully recanalized. The mean stent diameter for this
group was 6 mm (SD 1.2, range, 4-7) which also did not
Fig 2. Kaplan-Meier curves for freedom from occlusio
covered stent and the dashed line represents those treat
occlusion between the two groups was not statistical
uncovered): 0.5 (0.2-1.4), P  0.2.differ from the patent stent group diameter. Four out of fivehad a30% deterioration in GFR at the time of occlusion,
all of which have been sustained throughout the follow-up
period. Freedom from renal stent occlusion in the two
groups is presented in Fig 2.
Timing and etiology of renal stent occlusions. Most
(11 of the 18) renal stent occlusions occurred prior to the
1-month CT scan. The remaining seven occlusions oc-
curred between the 1-month and 6-month studies. There
were no late renal stent occlusions.
Of the 11 patients in whom renal stent occlusion was
apparent at the first postoperative visit, 4 were related to
procedural dissections, 3 had multiple overlapping stents
placed into a tapered luminal diameter renal artery, 3 had
renal stents that were compressed by angulation between
the fenestration and renal artery origin, and in 1 patient no
etiology was discovered.
Of the 7 patients in whom renal stent occlusions devel-
oped between the 1-month and 6-month visits, five oc-
curred on the right side and two on the left side. Three
patients had kinks visible between the right renal stent and
the artery distal to the stent, 2 had multiple overlapping
stents placed into a smaller lumen in the distal renal artery,
1 had periprocedural embolization to the kidney, and in 1
patient no etiology was discovered (Table III).
Revised duplex scan criteria for occlusions.
Occlusions are suggested by a lack of flow seen in the renal
months. The solid line represents those treated with a
th an uncovered stent. The development of renal stent
ferent. Hazard ratio (HR) for occlusion (covered vsn in
ed wi
ly difartery stent or PSV 57 cm/s and RAR 1.2. If the renal
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should also raise concern for a possible occlusion and
correlation made to the CT scan (Table IV, Fig 3).
Renal stent stenosis. A total of 30 out of 287 (10%)
uncovered stents developed a stenosis in follow-up. The
mean time to detection of stenosis was 16 months (SD
14.4, range, 1-48) and none were present during the
immediate postprocedure period. There was no change
in renal size pre- and post-stenosis. Six of these 30
stenoses were treated by secondary intervention for de-
teriorating renal function or progression of the stenosis
with repeated stenting and all six remain patent and free
of stenosis.
A total of six of 231 (2.5%) covered stents developed
a stenosis in follow-up. The mean time to detection
of stenosis was 10 months (SD 12.4, range, 1-36) and
none were present during the immediate postprocedure
period. There was no change in renal size pre- and
post-stenosis. One patient who had a stenosis with an
associated renal stent fracture underwent secondary in-
tervention with repeated stenting and remains patent
and free of stenosis.
Freedom from renal stent stenosis in the two groups is
presented in Fig 4. The HR for stenosis when comparing
covered vs uncovered stents is 0.4 (95% CI 0.2 to 0.9,
P  .04) favoring the use of a covered stent. GFR pre-
procedure, at the time of stenosis detection and at 1-year
post-detection for patients with ultrasound scan-detected
renal stenosis did not differ significantly. Covered stent
stenosis occurred only at the distal stent edge whilst uncov-
ered stent stenosis occurred at both the proximal and distal
portions of the stent.
Revised duplex scan criteria for stenoses. Using the
revised criteria, a 60-99% renal artery stent stenosis in a
fenestrated endograft is best detected using thresholds for
PSV 280 cm/s (sensitivity [Sn] 93%, specificity [Sp]
100%, PPV 99%,NPV 99%) or RAR4.5 (Sn 83%, Sp 89%,
PPV 42%, NPV 98%) (Table IV and Fig 4).
Physiologic renal dysfunction. Overall, 20% (31) of
the patients treated with uncovered renal stents had a sus-
tained 30% deterioration in GFR (Fig 5). Of these 31
patients, renal arterial defects were noted by duplex scan
studies in 15 patients (8 stenoses and 7 occlusions). The
remaining 16 of 31 patients who developed renal dysfunction
Table III. Etiology of renal artery stent occlusion
Renal artery stent occlusions – etiology Number %
Procedural dissection 6 33
Kink – at proximal renal stent 3 17
Kink – at distal stent edge 3 17
Small renal artery (4 mm, accessory
renal artery) 3 17
Procedural embolization 1 6
Unknown 2 10
TOTAL 18 100had deficits that were attributed to periprocedural renal em-bolization and/or contrast nephropathy. Renal infarcts were
observed in the postoperative CT scans in 50% (8/16) of this
subgroup. A total of 7 patients required hemodialysis during
follow-up (3 temporary and 4 permanent). Two new-onset
dialysis patients had renal occlusions, none had renal stenoses,
and 5 had their renal insufficiency attributed to embolization
or contrast nephropathy.
Covered renal stents were used in 129/287 patients, of
which 16% (21) patients had a sustained 30% deteriora-
tion in GFR (Fig 6). Of these 21 patients, no duplex
scan-detected renal stent stenoses were found. Renal occlu-
sions were noted in 4 patients during follow-up. Renal
dysfunction progressed to require dialysis in 2 of the 4
patients with renal occlusions (1 temporary and 1 perma-
nent dialysis). The remaining 17 of 21 patients who devel-
oped worsening renal function had their deficit attributed
to periprocedural renal embolization and/or contrast ne-
phropathy. Renal infarcts were observed in the postopera-
tive CT scan in 40% (8/17) of this subgroup, and of these,
4/17 required dialysis during the course of follow-up
(2 temporary and 2 permanent).
DISCUSSION
The vast majority of renal stents in patients treated with
fenestrated and branched devices for aneurysmal disease
remain stable during follow-up. There was a low risk of
severe renal complications (only 2% cumulative incidence
of new permanent dialysis requirement) despite the preva-
lence of renal insufficiency of the patient population prior
to treatment of aneurysms that involve or abut the renal
arteries. These results compare favorably with surgical series
for both juxtarenal aneurysms21 and thoracoabdominal
aneurysms.22,23 However, when stringent assessment crite-
ria were applied to our patient population, 20% of patients
were noted to develop some level of physiologic renal
dysfunction, 7% developed renal stenoses, and 3% devel-
oped occlusions. Much like the results of contemporary
renal stenting trials,24 the minority of renal functional
deficits in this series can be attributed to renal artery pathol-
ogy. The most common causes of renal dysfunction
included embolization of atheromatous debris or the
development of a nephropathy that may be associated
with contrast administration. However, there was a sig-
nificant subset of patients who developed renal dysfunc-
tion as a result of arterial lesions created by the procedure
or device. Therefore, it remains critical for clinicians to
have non-invasive methods allowing for the accurate
assessment of renal arteries following treatment of these
complex aneurysms. The absence of defined duplex scan
criteria, the lack of correlation between CT imaging
studies and other studies, and the inability to define the
need or benefit from intended secondary interventions
hamper follow-up paradigms after treatment with these
devices.
The detection of native renal artery stenoses is well
established. The sensitivity and specificity of duplex ultra-
sound scan, when done in an accredited vascular lab, has
been touted to be greater than 98% for de novo renal
ratio;
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renal artery into the aorta on turbulence and arterial veloc-
ity, there remains debate as to the optimal ultrasound scan
criteria indicative of renal stenosis.14-17 In the setting of a
renal stent in conjunction with an aortic stent graft, where
the aortic velocities are also altered, conventional duplex
scan criteria indicative of stenosis must be carefully ques-
tioned.
The absence of a non-invasive gold standard to define
renal artery pathology resulted in the comparison of two
imaging datasets (CT and duplex scan) which have both
been advocated as ameans to assess renal arterial pathology.
The strong correlation between the two results (ROC
r values 0.88 to 0.99; Figs 1 and 2) adds credence to the
concept that renal artery lesions can be detected non-
invasively using either modality. The resulting ROCs also
provide a means to refine duplex scan criteria, minimizing
the risk of false positive diagnoses, and improve the sensi-
Fig 3. Parametric receiver operator curve (ROC) analysis for the
detection of renal stent occlusion using peak systolic velocity (PSV)
and renal aortic ratio (RAR). For PSV the area under the ROC
curve is 0.91 (95% confidence interval [CI] 0.88-0.94) indicating
good discrimination between those with stent occlusion and no
occlusion. For RAR the area under the ROC curve is 0.88 (95% CI
0.84-0.91) indicating good discrimination between those with
stent stenosis and no stenosis.
Table IV. Revised ultrasound criteria for the detection an
patients with fenestrated or branched endografts
Renal stent stenosis Revised ultrasound criteria
60% stenosis PSV 57-280 cm/s
60-99% stenosis PSV 280 cm/s and/or RAR 4.5
Occlusion No flow seen in renal artery stent OR PSV
and RAR 1.2 (or unable to determine
because proximal RA not visualized)
CT, Computed tomography; PSV, peak systolic velocity; RAR, renal aortictivity and specificity of the technique (Table III). A total of18 patients with uncovered stents and 11 patients with
covered stents had a false positive elevated velocity on
duplex scan. This exemplifies the need for specific training
of ultrasound scan technicians to properly interrogate a
branched or fenestrated graft. Similarly, the construct of
curved planar reconstructions through renal artery stents
also required a defined skill set. Both techniques are useful
during the follow-up of such patients, and should be devel-
oped at each center employing these endovascular thera-
pies. Given that the methods correlate well with each other,
they may serve as a means for validation or onemethodmay
be used in the absence of other data.
The management of patients with diagnosed renal ar-
tery pathology evolved throughout the course of the trial.
The initial aggressive approach was likely not warranted
given the somewhat benign natural history of most renal
lesions in this setting as evidenced by the lack of progres-
sion of disease. It is difficult to determine the exact criteria
which prompted intervention as the study progressed,
given that our understanding of the need for treatment
evolved. However, in general, any clinical evidence of renal
dysfunction in conjunction with evidence of renal arterial
pathology resulted in further investigation. Renal stenoses
underwent confirmatory angiography with angioplasty and
stenting in the setting of significant stenoses (50% angio-
graphic stenosis postprocedure). However, the majority of
renal stenoses were not treated, particularly in the setting of
preserved renal function, or when patients were considered
unfit for secondary procedures. Overall, in the setting of
preserved renal function, 17% of patients with uncovered
stents, and 5% of patients with covered stents developed
renal stenoses. This compares to 39% of patients who had a
pre-existing 75% angiographic renal artery stenosis prior
to stent graft placement. We could not correlate the pres-
ence of preoperative renal artery stenosis with any postop-
erative outcome. Of the 36 patients with documented renal
stenoses diagnosed at a mean time of 15 months following
device implantation, 28 had no evidence of renal function
deterioration during follow-up of 24 months after the
detection of the stenosis. Patients treated with uncovered
stents who developed renal dysfunction only had a detect-
able renal artery lesion 50% of the time. Similarly, patients
treated with covered stents who developed renal dysfunc-
ding of renal artery stent stenosis and occlusion in
CT criteria
As visualized from centerline of flow and curved
planar reconstructions
As visualized from centerline of flow and curved
planar reconstructions
cm/s Lack of contrast enhancement through the lumen of
the stent on centerline and curved planar
reconstruction and marked difference in renal
parenchymal opacification in 3D reconstructions
RA, renal artery; 3D, three-dimensional.d gra
57
RARtion had detectable lesions only 20% of the time. Our
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tion, worsening stenosis or occlusion, secondary interven-
Fig 4. Kaplan-Meier curves for freedom from stenosis in
stent and the dashed line represents those treated with
between the two groups was statistically different. Hazard
P  .04.
Fig 5. Parametric receiver operator curve (ROC) analysis for the
detection of renal stent stenosis using peak systolic velocity (PSV)
and renal aortic ratio (RAR). For PSV the area under the ROC
curve is 0.99 (95% confidence interval [CI] 0.99-1.00) indicating
optimal discrimination between those with stent stenosis and no
stenosis. For RAR, the area under the ROC curve is 0.91 (95% CI
0.82-0.96) indicating good discrimination between those with
stent stenosis and no stenosis.tions should be considered. However, in the absence ofrenal dysfunction, asymptomatic stable renal artery lesions
are observed.
Renal occlusions behaved differently when contrasted
with renal stenoses. Most of the renal occlusions were
attributed to technical issues encountered during the im-
plantation procedure. This was evidenced by the early
appearance of the renal occlusions relative to renal stenoses
(mean time to occlusion diagnosis was 4 and 3 months for
uncovered and covered stents, in contrast to stenosis diag-
nosis at 17 and 10 months, respectively). The most com-
mon causes of renal occlusions included dissection and
excessive tortuosity, two factors that are extremely difficult
to rectify with secondary procedures. Two renal occlusions
occurred when accessory renals, that were quite small, were
incorporated into the repair. However, most renals that
occluded were not small, given that the mean balloon size
used to deploy stents into renal arteries that ultimately
occluded was 6.3 mm. A subset of patients with renal
occlusions were selected for attempted endovascular recan-
alization (no open surgical revascularization procedures
were performed). Although two attempted recanalizations
were successful, with patent renal arteries noted on
follow-up studies thereafter, renal function measurably
improved in only 1 of these patients.
Observed differences in the development of stenoses
in patients treated with uncovered and covered stents
merits discussion (Figure 7). Most renal stenoses associ-
ths. The solid line represents those treated with a covered
covered stent. The development of renal stent stenosis
(HR) for stenosis (covered vs uncovered): 0.4 (0.2-0.9),mon
an un
ratioated with uncovered stents were located at the proximal
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placement of covered stents occurred at the distal end of
the stent. When placing fenestrated or branched grafts,
the proximal aspect of renal stents and stent grafts were
flared in an attempt to rivet the graft material to the renal
artery or seal against the reinforced nitinol ring. Over
dilation such as this has been associated with intimal/
medial injuries, and a hyperplastic response potentially
resulting in late restenosis.25,26 Coverage of the injured
segment with graft material likely impedes the ingrowth
of tissue by simply forming a physical barrier, or render-
ing the arterial wall ischemic. Distal renal arterial lesions
likely have an alternative explanation. Inspiration and
expiration result in considerable renal motion, which
appears to have the greatest effect at the distal edge of the
renal stent (see web movie, online only). Additionally,
any tortuosity in the proximal renal artery is shifted
distally following placement of a balloon expandable
stent or stent grafts. This problem was compounded by
the fact that covered stents were more commonly placed
deeper into the renal vasculature than uncovered stents
(to establish firm fixation and sealing for thoracoabdomi-
nal aneurysms), resulting in exaggerated distal renal
artery kinking in some circumstances. Interestingly, this
Fig 6. Flow diagram demonstrating renal events during
stents. GFR, Glomerular Filtration Rate.was observed in conjunction with a renal stent occlusionmore often on the right renal artery rather than the left.
We hypothesize that the added anterior-posterior angu-
lation of the right renal artery as it dives under the
inferior vena cava (Figure 8) had a detrimental effect on
the patency of the vessel, as over 70% of all late occlu-
sions occurred on the right. Today, we are likely to
extend the balloon-expandable stent graft with a self-
expanding stent in an effort to taper the imposed stiff-
ness, creating a more smooth transition to a tortuous
distal renal segment. Given the overall benefit of covered
stents, one might question whether such devices should
be used for de novo renal artery stenoses as well.
The results reported in this analysis compare favor-
ably with other reports of experiences with similar de-
vices. Pooled literature results (including our earlier
report)27 estimate a 6% (95% CI 1.7-15%) incidence of
renal artery occlusion,28 and our observed incidence of
2% certainly falls within this range. Although there are
other reports of experiences with fenestrated and
branched devices,10,29-31 most do not have sufficient
information regarding detailed renal artery and renal
function analysis, or have limited enrollment to assess the
incidence of renal issues. Other investigators have sug-
gested that patients should be maintained on antiplatelet
w-up (F/U) of all patients treated using uncovered renalfollotherapy (including both aspirin and clopidogrel) indefi-
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not adopted this policy, and our patients were main-
tained only on aspirin indefinitely, unless otherwise in-
dicated.
There exist several limitations with this series. First
and foremost, the choice of stents was not randomized, and
thus there exists fundamental differences (anatomic and
physiologic) in the patient population. This remains as a
confounding variable in determining the potential for im-
proved efficacy of covered stents in the patient not requir-
ing concomitant aortic stenting. Further issues include the
absence of defined method of non-invasively assessing the
renal artery status after device implantation. Therefore,
although we assimilated two different methods for valida-
tion, the potential for both to reflect artifact or have fun-
damental errors exists. Finally, temporal disparities in en-
rollment relegate to two treatment groups to different
Fig 7. Flow diagram demonstrating renal events durin
stents. GFR, Glomerular Filtration Rate.durations of follow-up. Will we see greater incidence of laterenal artery problems in the stent graft group as time goes
on? These issues serve as points of discussion for the design
of future trials intended to assess renal stenting, fenestrated
stent grafting, and complications following complex aneu-
rysm repairs.
The results from this study of 518 stented renal
arteries with a mean follow-up of over 2 years demon-
strate that there exists a low risk of posttreatment renal
failure progressing to require hemodialysis (2%) and a
cumulative incidence of renal occlusions in 3% of stented
arteries. Stenoses were more commonly noted when
uncovered stents were employed, although the natural
history of untreated renal artery stenosis following endo-
vascular treatment of complex aneurysms is rarely one of
progression to occlusion or worsening renal function.
The revised duplex scan criteria provided in conjunction
with available high resolution CT data will detect most
w-up (F/U) of all patients treated using covered renalg follorenal stenoses, allowing clinicians to then determine
JOURNAL OF VASCULAR SURGERY
April 2009836 Mohabbat et alwhether further intervention will be warranted on clini-
cal grounds.
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Dr Hasan Dosluoglu (Buffalo, NY): Was the finding of 7%
in-stent restenosis related to the preoperative presence of renal
artery disease? And if so, was there a difference between the bare
stents and the covered stents in those people who had preoperative
disease in their renal arteries?
Dr Walid Mohabbat. The difference in the two groups
pertains to the level of the aortic aneurysmal disease. We looked
back on all the patients that developed a stenosis and an occlusion,
and we looked at the operative records for evidence of renal artery
stenosis, and this was seen in about 20% of all cases. This was a poor
marker, however, so only in cases where there was a severe stenosis
was this mentioned on the operative report.
We feel that if we actually go back and look at the procedural
angiograms and the procedural videos from each case, we would
see a much higher incidence of renal artery stenosis preoperatively
in both groups. However, we didn’t look at all cases for that
particular finding, so we don’t know, but we suspect that they are
comparable in both groups.
Dr Richard Cambria (Boston, Mass). If I understand your
information correctly, about 20% of your patients had a decrement
in renal function. So my first question to you is: What was the
percentage of patients who had either major deterioration in renal
function or who went on to dialysis?
And if Dr Greenberg would take the question, have you done
any retrospective look at the CT [computed tomography] scan
information? Are there specifics of anatomy that you correlated
with the embolization where—the other way of asking the ques-
tion—are there factors that you identified where youmight want to
avoid extensive juxtarenal endograft manipulation?
Dr Mohabbat.Well, firstly, to address the issue of emboliza-embolization on the postoperative CT scan, we went back and
looked at the preoperative CT scan and looked at the neck and also
the visceral segment of the aorta for thrombus formation and the
like. We did find that in each case with embolization, there was
aortic disease in the visceral segment with extensive thrombus
burden. However, when looking at a population with juxtarenal
and thoracoabdominal aortic aneurysms, whether this differed
between those who embolized and those who didn’t embolize we
don’t know.
DrRoyGreenberg. In answer to the first part of the question,
there were only about three or four patients in the entire series that
progressed to dialysis. For the purposes of this analysis, we took a
very aggressive stance with respect to identification of changes in
the baseline GFR [glomerular filtration rate]. Any drop in GFR
30%, irrespective of the absolute GFR level, was considered
significant. Therefore, even if a patient’s creatinine was 0.8 at the
beginning of the procedure and it changed to during follow-up to
1.3, that was included in the group with deterioration of renal
function. So in the manuscript you will see there are a lot of details
in terms of how severe that dysfunction was. The relevance of a 30%
change in the context of an otherwise normal GFR is subject to
speculation.
With respect to analysis of patients suffering embolization, we
could not determine any predictive. Thoracoabdominal aneurysms
frequently have a lot of debris above the renal arteries. This is
inherent with the disease, but thoracoabdominal aneurysms did
not fare worse in terms of long-term renal function in contrast to
juxtarenal aneurysms. Thus, the extent of aneurysmal disease was
not associated with worse renal function. When we specifically
looked at the patients suffering embolization, the numbers were
too small to develop any statistical relevance.
